In Silico Dual Inhibitors for ADAM17
Salva questo lavoro e mantieni la tua ricerca organizzata
Crea un account gratuito per salvare lavori, creare avvisi e tornare a questa inserzione dalla tua dashboard.
Continuando accetti i nostri Termini & Informativa sulla privacy.
The UNIMORE in Italy is seeking a researcher to design and develop dual inhibitors of ADAM17 and KRasG12C proteins as potential anti-tumour agents, using structure-based in silico methods.
Può ottenere maggiori dettagli sulla natura di questa posizione e sui requisiti per i candidati leggendo quanto segue.
An evaluation of structure-activity relationships on the developed compounds will be carried out, with the final goal of identifying molecules with high xysqume efficacy and selectivity that could be applicable to non-small cell lung cancer treatment.